Key facts
- It has raised $2.0M; the latest was Accelerator/Incubator in Oct 2025.
- Notable investors include Endless Frontier Labs, Virginia Innovation Partnership Corporation, Virginia Venture Partners, AFWERX, U.S. Department of Health and Human Services.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Perfusion Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Perfusion Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Perfusion Medical
Operator of a biopharmaceutical company intended to develop lifesaving, acute cardiovascular therapies to transform critical care medicine, with a focus on shock and ischemic conditions. The company addresses severe blood loss and related medical conditions by increasing tissue perfusion and reversing metabolic cell and tissue swelling, enabling healthcare professionals to reduce the need for fresh whole blood or blood products in the far-forward battle space, synergistically enhancing the resuscitative efficacy of blood products when used.
- Sector
- Healthcare
- HQ
- Reston, VA, United States
- Founded
- 2020
- Employees
- 9
- Website
- perfusionmedical.com/
- Ownership
- Privately Held (backing)
Perfusion Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Perfusion Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Perfusion Medical in its N-PORT filings yet. We sweep new filings monthly.